Bio-Rad Laboratories
(NYSE) BIO
Bio-Rad Laboratories Financials at a Glance
Market Cap
$7.54B
Revenue (TTM)
$2.59B
Net Income (TTM)
$168.80M
EPS (TTM)
$6.07
P/E Ratio
46.39
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$283.19
Volume
5,003
Open
$283.00
Price
$283.19
Volume
5,003
Open
$283.00
Previous Close
$281.82
Daily Range
$275.98 - $283.19
52-Week Range
$211.43 - $343.12
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$283.19
Volume
5,003
Open
$283.00
Previous Close
$281.82
Daily Range
$275.98 - $283.19
52-Week Range
$211.43 - $343.12
BIO News
BIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bio-Rad Laboratories
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
7,400
CEO
Norman D. Schwartz
Website
www.bio-rad.comHeadquarters
Hercules, CA 94547, US
BIO Financials
Key Financial Metrics (TTM)
Gross Margin
52%
Operating Margin
9%
Net Income Margin
7%
Return on Equity
2%
Return on Capital
3%
Return on Assets
2%
Earnings Yield
2.16%
Dividend Yield
0.00%
Payout Ratio
19.73%
Stock Overview
Market Cap
$7.54B
Shares Outstanding
26.76M
Volume
5.00K
Avg. Volume
337.92K
Financials (TTM)
Gross Profit
$1.34B
Operating Income
$270.50M
EBITDA
$475.90M
Operating Cash Flow
$532.20M
Capital Expenditure
$157.60M
Free Cash Flow
$374.60M
Cash & ST Invst.
$1.54B
Total Debt
$1.53B
Bio-Rad Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$592.10M
+1.1%
Gross Profit
$309.40M
+1.1%
Gross Margin
52.25%
N/A
Market Cap
$7.54B
N/A
Market Cap/Employee
$979.47K
N/A
Employees
7,700
N/A
Net Income
$527.10M
-923.6%
EBITDA
$677.50M
-607.5%
Quarterly Fundamentals
Net Cash
$186.50M
-35.9%
Accounts Receivable
$439.50M
+3.5%
Inventory
$0.00
-100.0%
Long Term Debt
$941.50M
-29.1%
Short Term Debt
$436.70M
+927.5%
Return on Assets
1.72%
N/A
Return on Invested Capital
2.70%
N/A
Free Cash Flow
$78.10M
-18.2%
Operating Cash Flow
$108.10M
-16.8%